Circadian Function and Cardio-metabolic Risk in Adrenal Insufficiency

NCT03000231 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2024-02-28

No results posted yet for this study

Summary

The purpose of this study is to compare cardio-metabolic risk, glucose tolerance, and night time blood pressure between healthy control subjects and patients with adrenal insufficiency. No intervention will be administered and the study is observational only.

Conditions

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Eve Van Cauter, Ph.D. · University of Chicago

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03000231 on ClinicalTrials.gov